BioStock: Alzinova's CMO wants to bring forward a vaccine against Alzheimer's

Last fall, Dr Kirsten Harting joined Alzinova as the new Chief Medical Officer (CMO). Harting brings profound expertise from working with brain disorders including Alzheimer’s disease as well as knowledge about vaccines and immunotherapy. Roughly a half year into her tenure as CMO, BioStock reached out to Kirsten to learn more about her ambitions to shape Alzinova’s trajectory as the company advances in its Alzheimer’s clinical trials.

Read the full interview with Kirsten Harting at biostock.se:

https://www.biostock.se/2024/01/alzinovas-cmo-wants-to-bring-forward-a-vaccine-against-alzheimers/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/